The Global Gamma Knife Market: An Overview

The global gamma knife market is a specialized and growing segment of the medical device industry, driven by the increasing demand for non-invasive and highly precise neurosurgical treatments. Gamma Knife radiosurgery is a type of stereotactic radiosurgery that uses highly focused beams of gamma radiation to treat small tumors and other abnormalities in the brain with minimal damage to surrounding healthy tissue. It is a non-invasive procedure, meaning there is no incision, and it is performed in a single session or a few sessions, offering a safer alternative to traditional open-brain surgery. The market was valued at USD 0.56 billion in 2024 and is projected to reach USD 0.93 billion by 2034, growing at a CAGR of 5.20% during this period. This growth is a result of the rising prevalence of neurological disorders, technological advancements, and the growing preference for minimally invasive procedures.

The market is segmented by disease indication, anatomy, and end-user. Key applications include the treatment of brain metastases, malignant and benign tumors, arteriovenous malformations (AVMs), and functional disorders like trigeminal neuralgia. The end-user segment is dominated by hospitals, which are the primary centers for advanced neurosurgical treatments. The competitive landscape is characterized by a few major players who are constantly innovating to improve the precision, speed, and overall patient experience of Gamma Knife treatments.